MEG3 has been shown to have antitumor activity in different cancer cells, such as breast, liver, glioma, colorectal, cervical, gastric, lung, ovarian, and osteosarcoma cancer cells [30]. This evidence concerns the gene MEG3 and central nervous system cancer.